NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
REDRipretinib Qinlock®
(50mg tablets) 		Malignant disease and immunosuppression, Protein kinase inhibitors, 08.01.05
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Ripretinib Ripretinib [Specialist Drug] Malignant Disease, Antineoplastic Drugs, Protein Kinase Inhibitors
Targeted Therapy Responsive Malignancy
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA1146: Ripretinib for treating advanced gastrointestinal stromal tumours after 3 or more kinase inhibitors
NICE TA881: Ripretinib for treating advanced gastrointestinal stromal tumour after 3 or more treatments